Navigation Links
Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.
Date:10/25/2011

e benefits were partially offset by a reduction of the proportion of income in foreign jurisdictions with lower tax rates.

Free cash flow (defined on page 7) for the first nine months of 2011 was $300 million, compared to $332 million achieved in the same period in 2010. Higher net income was largely offset by a higher level of working capital and capital expenditures to support growth in the business.   A reconciliation of net cash provided by operating activities to free cash flow is on page 9.

Other highlights from global sales growth initiatives include:

  • Worldwide sales of research products through the Company's website as a percentage of total research sales were 50% for the third quarter of 2011, consistent with the performance in the first half of 2011 and up from 48% achieved for all of 2010.
  • Sales in International markets (Asia Pacific and Latin America) continued to show strength with reported and organic growth of 22% and 9%, respectively, in the third quarter of 2011.  The acquisition of Vetec increased reported international sales by 5% for the quarter. In the Company's focus markets of China, India and Brazil, sales collectively grew 46% and 25% on a reported and organic basis, respectively, for the third quarter of 2011. The acquisition of Vetec increased reported sales in these focus markets by 16%.
  • SAFC's booked orders for future delivery at September 30, 2011 were up 3% from the June 30, 2011 level and up 6% from the September 30, 2010 level.

  • 2011 OUTLOOK:

  • Organic sales growth is expected to be in the mid-single digit range for 2011, unchanged from our previous outlook. Significant factors in our sales outlook include:
  • Continued uncertainty in the U.S. and Europe around the macro economic environment and austerity measures is adding a layer of instability to our end markets.  We are cautiously optimistic that our programs to enhance and highlight the product capabil
    '/>"/>

  • SOURCE Sigma-Aldrich
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
    2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
    3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
    4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
    5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
    6. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
    7. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
    8. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
    9. Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
    10. Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)
    11. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ... six months ended June 30, 2015 and updated its ... earnings conference call this morning, August 4, 2015, at ... join the call by dialing (855) 582-8078. The conference ... , Year-to-date net revenues of $38.3 million, an increase of ...
    (Date:8/4/2015)... , Aug. 4, 2015  Ironshore Pharmaceuticals & ... Restore Health, a company specializing in personalized medicine, ... clinical trial, designed to evaluate the safety and ... to treat Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s ... Restore Health originally partnered with Ironshore in 2014 ...
    (Date:8/3/2015)... WEST JORDAN, Utah , Aug. 3, 2015  BC ... Solutions has acquired Ohio Valley Medical Systems, one of ... MRI systems.  The addition of Ohio Valley Medical Systems ... to now include Hitachi MRI.   "We ... Mark Alvarez , President and CEO of BC Technical. ...
    Breaking Medicine Technology:ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2BC Technical Acquires Ohio Valley Medical Systems 2
    ... Clinical Trial to be Presented at Retrovirus ConferenceLEXINGTON, Mass., ... IDEV ) announced today that a National Institutes of ... received PRO 2000, the Company,s candidate vaginal microbicide for ... acquiring HIV infection than women who received a placebo ...
    ... The U.S. Agency for International Development (USAID) continues to ... in the midst of an expanding humanitarian crisis. An ... left the people of Zimbabwe in danger of other ... is supporting emergency Indoor Residual Spraying (IRS) to shore ...
    Cached Medicine Technology:Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 2Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 3Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 4Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 5Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 6USAID Provides Malaria Assistance to Zimbabwe 2
    (Date:8/4/2015)... ... , ... Updated enrollment data on the top U.S. health plans, as collected ... http://www.AISHealth.com . The data is free to all registered users to AISHealth.com. Based ... on the website’s “Data” section include:, , Top 25 U.S. ...
    (Date:8/4/2015)... ... August 04, 2015 , ... The results of a three year clinical ... rare eye disease that progressively causes blindness, were published on June 23, 2015 in ... results of the trial, the implant, more commonly known as the “bionic eye,” is ...
    (Date:8/4/2015)... Miramar Beach, FL (PRWEB) , ... August 04, 2015 , ... ... people are living with psoriatic disease and its uncomfortable symptoms such as dry, itching, ... suffer from psoriasis bounce from medication to medication before they find what’s right for ...
    (Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... as one of 20 finalists for America’s Favorite Veterinarian. The contest is put ... by a judging committee from 500 nominees. Nominees were evaluated on community involvement, ...
    (Date:8/4/2015)... ... August 04, 2015 , ... Loyola University New Orleans, ... RN to BSN and Master of Science in Nursing in Health Care ... from the Commission on Collegiate Nursing Education (CCNE), the nation’s foremost ...
    Breaking Medicine News(10 mins):Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 2Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 3Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4
    ... have claimed that body's immune system can be used as ... cancer. //Patients whose immune system was enhanced by drugs lived ... ,Two research teams in the U.S. were able to improvise ... were presented at a conference on cancer research at Prague. ...
    ... be the latest in a series of outbreaks this ... //Still Perrigo Company, the world's largest manufacturer of generic ... At a cost of $2.9 million, the company has ... painkiller it made for retailers like CVS, Wal-Mart, and ...
    ... Stem cells have captured the imagination of the world as ... cajoled into restoring or rejuvenating debilitating organs. //Research carried ... reiterate this belief, by restoring sight in mice which suffered ... ,This amazing work, which was published in 'Nature', could be ...
    ... Deutsche Forschungsgemeinschaft (DFG), //called for review of the Stem Cell ... ,In a statement, the DFG said, 'The 2002 Stem ... key date regulation and the penalties established in the Stem ... new cell lines and, to a large extent, prevented from ...
    ... cancer and deaths from the disease are alarming. According to ... cancer have been reported in Canada and 8,500 deaths from ... is 140,000 cases and 55,000 deaths, as reported by the ... the numbers at 34,900 cases and 16,000 deaths. ...
    ... per week are protected from developing prostate cancer//, as the ... has revealed. , ,The study that is available online ... consuming omega-3 fatty acids in protecting against cardiovascular disease (CVD), ... positively impact mood and behavior. ,Nearly half a million ...
    Cached Medicine News:Health News:New Treatment For Skin Cancer Using Body's own Immune System 2Health News:Voluntary Recall Of Tainted Painkillers 2Health News:Research 'Extraordinaire' To Restore Vision 2Health News:German Scientists Call For Review Of Stem Cell Act 2
    ... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
    Medicine Products: